Deconvoluting Low Yield from Weak Potency in Direct-to-Biology Workflows with Machine Learning
Preprint
- 9 February 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
High throughput and rapid biological evaluation of small molecules is an essential factor in drug discovery and development. Direct-to-Biology (D2B), whereby compound purification is foregone, has emerged as a viable technique in time efficient screening, specifically for PROTAC design and biological evaluation. However, one notable limitation is the prerequisite of high yielding reactions to ensure the desired compound is indeed the compound responsible for biological activity. Herein, we report a machine learning based yield-assay deconfounder capable of deconvoluting low yield from low potency to identify false negatives. We validated this approach by identifying promising SARS-CoV-2 main protease inhibitors with nanomolar activity that rivaled potency observed from the standard D2B workflow. Furthermore, we show how our framework can be utilized in a broad, in silico screen with to produce compounds of similar potency as a D2B assay.Keywords
All Related Versions
Funding Information
- Israel Science Foundation (3824/19)
This publication has 24 references indexed in Scilit:
- Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACsJournal of Medicinal Chemistry, 2023
- Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitorsSTAR Protocols, 2021
- MetaClean: a machine learning-based classifier for reduced false positive peak detection in untargeted LC–MS metabolomics dataMetabolomics, 2020
- An Overview of Machine Learning and Big Data for Drug Toxicity EvaluationChemical Research in Toxicology, 2019
- AVP‐IC 50 Pred: Multiple machine learning techniques‐based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC 50 )Peptide Science, 2015
- Cheminformatics approaches to analyze diversity in compound screening librariesCurrent Opinion in Chemical Biology, 2010
- Predicting Lipophilicity of Drug‐Discovery Molecules using Gaussian Process ModelsChemMedChem, 2007
- Gaussian Processes: A Method for Automatic QSAR Modeling of ADME PropertiesJournal of Chemical Information and Modeling, 2007
- Random Forest Models To Predict Aqueous SolubilityJournal of Chemical Information and Modeling, 2006
- Random Forest: A Classification and Regression Tool for Compound Classification and QSAR ModelingJournal of Chemical Information and Computer Sciences, 2003